Boston Scientific Corporation 's BSX successful result from its WHISPER randomized controlled trial (RCT) further boosts its neuromodulation business. This announcement follows the recent FDA approval ...

Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, ...

The global Neuromodulation Market , valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to ...

Nevro is the top pure play spinal cord stimulation [SCS] company with three major industry competitors. Nevro's recent FDA approvals for its high frequency SCS system in treatment of painful diabetic ...

DUBLIN--(BUSINESS WIRE)--The "Neuromodulation Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Neuromodulation is an intracranial, ...

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...

MILAN & BERLIN--(BUSINESS WIRE)--WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, today announced the ...

Fort Lauderdale-based company Stimwave Technologies announced today that its eight-electrode wireless, micro-technology neuromodulation device for relief of chronic back and leg pain received FDA ...

We’ve long viewed neuromodulation as a field that offered great promise but faced meaningful challenges to realizing that potential. Thanks to a spurt in innovation in spinal cord stimulation--the ...

Medtronic plc MDT announced a major regulatory advancement in the fast-growing neuromodulation space. Per the announcement, the company received revised commercial labeling approval from the FDA for ...